Myelin-associated glycoprotein (MAG) and Nogo are potent inhibitors of neurite outgrowth from a variety of neurons, and they have been identified as possible components of the central nervous system myelin that prevents axonal regeneration in the adult vertebrate central nervous system. The activation of RhoA and Rhokinase is reported to be an essential part of the signaling mechanism of these proteins. Here, we report that the collapsing response mediator protein-2 (CRMP-2) is phosphorylated by a Rho-kinasedependent mechanism downstream of MAG or Nogo-66. The overexpression of the nonphosphorylated form of CRMP-2 at threonine 555, which is the phosphorylation site for Rho-kinase, counteracts the inhibitory effect of MAG on the postnatal cerebellar neurons. Additionally, the expression of the dominant negative form of CRMP-2 or knockdown of the gene using small interference RNA (siRNA) mimics the effect of MAG in vitro. Consistent with the function of CRMP-2, which promotes microtubule assembly, microtubule levels are down-regulated in the cerebellar neurons that are stimulated with MAG in vitro. Reduction in the density of microtubules is also observed in the injured axons following the spinal cord injury, and this effect depends on the Rho-kinase activity. Our data suggest the important roles of CRMP-2 and microtubules in the inhibition of the axon regeneration by the myelin-derived inhibitors.Several myelin-derived proteins have been identified as components of the central nervous system myelin that prevents axonal regeneration in the adult vertebrate central nervous system. To date, three major inhibitors that are expressed by oligodendrocytes and myelinated fiber tracts have been identified (1). These are Nogo, myelin-associated glycoprotein (MAG), 2 and oligodendrocyte-myelin glycoprotein. All these proteins act on neurons through the p75 receptor (p75) (2-4) in complex with the Nogo receptor. One potential clue to understanding the signal transduction mechanism downstream of p75 and the Nogo receptor is found through observations that demonstrate the small GTPase RhoA as a key intracellular effector for growth inhibitory signaling by myelin. In its active GTP-bound form, RhoA rigidifies the actin cytoskeleton, thereby inhibiting axon elongation and mediating growth cone collapse. RhoA is activated by MAG, Nogo-66, and oligodendrocyte-myelin glycoprotein through a p75-dependent mechanism; thus, inhibiting neurite outgrowth from postnatal sensory neurons and cerebellar neurons (2-5). The regulation of RhoA activity by MAG and Nogo through p75 is mediated by the release of RhoA from Rho GDI, which suppresses the RhoA activity (6, 7).Although RhoA and one of its effectors, Rho-kinase, appear to play a key role in regulating axon growth, the mechanism by which the myelinderived proteins regulate axon outgrowth remains to be elucidated. The outgrowth of axons is based on the dynamic rearrangement of the cytoskeleton (8). Cues that influence the axon outgrowth are sensed by the growth cone, which is a highly mot...